MiNK Therapeutics, Inc. (INKT) Stock price, Description, News & Info
#Thinksabio latest news MiNK Therapeutics to Present Late-Breaking Data on AgenT-797 in Solid Tumors at...
#Thinksabio latest news MiNK Therapeutics to Present Late-Breaking Data on AgenT-797 in Solid Tumors at...
#Thinksabio latest news NextNRG to Bring Advanced Microgrid and EV Charging Solutions to Gulfstream Development...
#Thinksabio latest news Xilio Therapeutics to Present Phase 2 Data for Vilastobart Highlighting Response Rate...
#Thinksabio latest news FUSEW – Fusemachines Launches Global Reseller Network to Expand Access to AI...
#Thinksabio latest news Red Cat’s FANG™ FPV Drone for Defense and Security Operations Receives Blue...
#Thinksabio latest news Creative Medical Technology Holdings, Inc. Ignites Next-Gen Regenerative BioDefense Initiative for U.S....
#Thinksabio latest news ARQT Mother-Daughter Duo, Tori Spelling and Stella McDermott, Partner With Arcutis Biotherapeutics...
#Thinksabio latest news POP Culture and Fu Xiang Culture Form Strategic Partnership to Co-build Two...
#Thinksabio latest news Core Scientific Announces Termination of Merger Agreement with CoreWeave
#Thinksabio latest news Abeona Therapeutics® Announces Permanent J-Code for ZEVASKYN® (prademagene zamikeracel)